Welcome to our dedicated page for Alphatec Holdings SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alphatec Holdings, Inc. filings document the reporting record of a spine-focused medical technology company. Its Form 8-K disclosures include quarterly and annual operating results, surgical and EOS revenue commentary, non-GAAP profitability measures, preliminary financial information and related press-release exhibits.
The company’s regulatory filings also cover material financing agreements, including senior secured credit facilities, revolving borrowing capacity, term-loan arrangements and references to convertible senior notes. Proxy and governance filings document director elections, board composition, executive and director compensation, equity awards, committee matters and other shareholder voting disclosures.
Alphatec Holdings, Inc. (ATEC) Form 144 notice: An insider intends to sell 2,555 shares of common stock on approximately 09/19/2025 on NASDAQ with an aggregate market value of $38,887.10 based on the filing. The shares were acquired as restricted stock units (RSUs) on 02/17/2024 and the filer reports the securities were issued by the company. The issuer's total shares outstanding is listed as 147,983,775. The filing also discloses recent 10b5-1 sales by the same person: 137,445 shares sold on 09/18/2025 for $2,073,742.67. The notice includes the standard representation that the selling person does not possess undisclosed material information and references reliance on a trading plan where applicable.
Alphatec Holdings, Inc. (ATEC) submitted a Form 144 notifying the proposed sale of 137,445 common shares through Morgan Stanley Smith Barney LLC on 09/18/2025 with an aggregate market value of $2,020,441.50. The filing shows these shares were acquired on 02/17/2023 as restricted and performance stock units (RSUs & PSUs) from the issuer, and there were no reported sales by the seller in the prior three months.
The shares to be sold represent a small fraction of the 147,983,775 shares outstanding. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. No payment arrangements or gifts are indicated.
Mortimer Berkowitz III, a director of Alphatec Holdings, Inc. (ATEC), reported a sale of common stock on 09/09/2025. The Form 4 shows he disposed of 62,500 shares at a weighted-average price of $15.97, reducing his reported direct beneficial ownership to 618,050 shares. The filing also discloses indirect holdings: 24,802 shares held by spouse and 146,575 shares each attributed to four separate 2016 trusts for Charlotte G., Thomas G., Hayward M., and William W. Berkowitz. The footnotes state the sale occurred in multiple transactions at prices ranging from $15.90 to $16.04 and that the reporting person disclaims beneficial ownership of the spouse-held shares except for pecuniary interest. The Form is signed by an attorney-in-fact on behalf of the reporting person on 09/11/2025.
Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a planned sale of 300,000 shares of ATEC common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted on June 3, 2025. The sales were executed at a weighted average price of $15.73 with individual transaction prices ranging from $15.53 to $15.96. Following the reported disposition, Mr. Patrick beneficially owned 5,564,078 shares directly, plus 10,900 shares held by an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was filed and signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. (symbol ATEC) submitted a Form 144 notifying a proposed sale of 300,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $4,770,000.00. The reported shares were acquired as Restricted Stock Units on 10/02/2020 and the acquisition and payment date is also listed as 10/02/2020. The filing shows 147,983,775 shares outstanding, and an approximate date of sale of 09/02/2025. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the selling person does not possess undisclosed material adverse information.
Alphatec Holdings, Inc. (ATEC) insider sale reported by Chief Operating Officer Lish Scott. The Form 4 shows that on 08/21/2025 the reporting person sold 6,323 shares of Alphatec common stock under a Rule 10b5-1 trading plan adopted March 14, 2025, at a weighted average price of $16.01 per share. After the sale the reporting person beneficially owned 658,707 shares. The filer indicates the price range for the multiple transactions was $16.00 to $16.02 and that full allocation details are available on request. The form was signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings insider sale under 10b5-1 plan. Lish Scott, Chief Operating Officer of Alphatec Holdings, Inc. (ATEC), reported a sale of 9,302 shares of common stock on 08/13/2025 at a price of $16.00 per share. After this transaction the reporting person beneficially owned 665,030 shares, held directly. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating the transactions were prearranged rather than opportunistic trades. The Form 4 was submitted through an attorney-in-fact signature.
Miles Patrick, CEO and Director of Alphatec Holdings, Inc. (ATEC), reported an insider transaction on 08/14/2025. The filing shows a sale of 10,000 common shares and discloses beneficial ownership following the transaction of 5,864,078 shares directly, plus 10,900 shares held in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. filed a Form 144 reporting a proposed sale of 15,625 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $245,625. The sale is listed for execution approximately on 08/13/2025 on NASDAQ, against a total of 147,983,775 shares outstanding.
The securities were acquired on 02/24/2023 as 7,011 Performance Stock Units and 8,614 Restricted Stock Units, which together equal the 15,625 shares proposed for sale. The filing also discloses prior sales in the past three months totaling 152,688 shares for gross proceeds of approximately $1,971,447.50, several of which are identified as 10b5-1 plan transactions. The filer attests to no undisclosed material adverse information in connection with the notice.